Salvatore Thomas Butera - 22 Jan 2026 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Salvatore Thomas Butera
Issuer symbol
VNRX
Transactions as of
22 Jan 2026
Net transactions value
$0
Form type
4
Filing time
23 Jan 2026, 16:06:34 UTC
Previous filing
04 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Butera Salvatore Thomas CEO - Volition Veterinary 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON /s/ Salvatore Thomas Butera 23 Jan 2026 0001834339

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +53,400 +17% $0.000000 375,203 22 Jan 2026 Direct F1
holding VNRX Common Stock 99,350 22 Jan 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 17, 2025, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 53,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 17,800 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 124,600 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.
F2 These shares of common stock are jointly owned by the reporting person and his spouse.